Predict your next investment

Corporation
ethiconendo.com

See what CB Insights has to offer

Portfolio Exits

1

About Ethicon Endosurgery

Ethicon Endo-Surgery develops and markets advanced innovative medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology.

Ethicon Endosurgery Headquarter Location

4545 Creek Road

Cincinnati, Ohio, 45242,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ethicon Endosurgery

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Ethicon Endosurgery in 1 Expert Collection, including Medical Devices.

M

Medical Devices

232 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

Latest Ethicon Endosurgery News

Ethicon EndoSurgery Inc Strategic SWOT Analysis Review Report Updated 17082017 Prices from USD $125

Oct 10, 2017

15:15 EDT 10 Oct 2017 | BioPortfolio Reports Ethicon EndoSurgery Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services. This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Corporate strategy GlobalData's summarization of the company's business strategy. SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats. Company history Progression of key events associated with the company. Major products and services A list of major products, services and brands of the company. Key competitors A list of key competitors to the company. Key employees A list of the key executives of the company. Executive biographies A brief summary of the executives' employment history. Key operational heads A list of personnel heading key departments/functions. Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details. Key manufacturing facilities A list of key manufacturing facilities of the company. Highlights Ethicon EndoSurgery Inc Ethicon, a subsidiary of Johnson and Johnson , is a medical equipment company. It develops and markets surgical instruments and devices. Its major products include staplers, energy devices, clip appliers, trocars, hemostats, endocutters, suturing devices, endoscopic instruments, electrosurgical and irrigation products, meshes and allografts. Its products are used in minimally invasive and open surgical procedures to treat colorectal, thoracic, and women's health conditions, hernias, cancer and obesity. Ethicon also offers ultrasonic energy devices and advanced bipolar energy devices. The company has medical education and surgical training, manufacturing, and sales facilities in the Americas, Europe and AsiaPacific. Ethicon is headquartered in Cincinnati, Ohio, the US. Ethicon EndoSurgery Inc Key Recent Developments Jul 13,2016: Ethicon Study: Bariatric Surgery Found To Be A More Effective Way To Control Diabetes In Obese Asian Indian Patients Apr 26,2016: Ethicon's Harmonic Devices Shown To Be More Cost Effective Than Conventional Methods In Thyroidectomy Apr 05,2016: Five Year Data from EthiconFunded Study Demonstrates LongTerm Benefit of Bariatric Surgery for Control of Diabetes Mar 01,2016: Ethicon Receives Innovative Technology Designation From Vizient Reasons to Buy Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy. Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance. Note: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Ethicon Endosurgery Portfolio Exits

1 Portfolio Exit

Ethicon Endosurgery has 1 portfolio exit. Their latest portfolio exit was Systagenix on December 01, 2008.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/1/2008

Divestiture

1

Date

12/1/2008

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

1

Ethicon Endosurgery Acquisitions

4 Acquisitions

Ethicon Endosurgery acquired 4 companies. Their latest acquisition was Megadyne Medical Products on January 20, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/20/2017

Acquired

1

9/16/2011

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/23/2008

Unattributed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

6/7/2004

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/20/2017

9/16/2011

10/23/2008

6/7/2004

Investment Stage

Series A

Unattributed VC - II

Series D

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

Total Funding

$99M

$99M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.